Stereotactic Body Radiotherapy for Medically Inoperable Stage I-II Non–Small Cell Lung Cancer: The Mayo Clinic Experience

OBJECTIVE: To examine disease control and survival after stereotactic body radiotherapy (SBRT) for medically inoperable, early-stage non–small cell lung cancer (NSCLC) and determine associations of pretreatment (18)F-fluorodeoxyglucose–positron emission tomography (FDG-PET) maximum standardized upta...

Descripción completa

Detalles Bibliográficos
Autores principales: Hobbs, Corey J., Ko, Stephen J., Paryani, Nitesh N., Accurso, Joseph M., Olivier, Kenneth R., Garces, Yolanda I., Park, Sean S., Hallemeier, Christopher L., Schild, Steven E., Vora, Sujay A., Ashman, Jonathan B., Rule, William G., Bowers, Johnny R., Heckman, Michael G., Diehl, Nancy N., Miller, Robert C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124323/
https://www.ncbi.nlm.nih.gov/pubmed/30225431
http://dx.doi.org/10.1016/j.mayocpiqo.2017.11.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124323/
https://www.ncbi.nlm.nih.gov/pubmed/30225431
http://dx.doi.org/10.1016/j.mayocpiqo.2017.11.001

Ejemplares similares